Nanostructured Lipid Carriers: An Innovative Approach To Drug Delivery
International Journal of Drug Delivery Technology · 18.05.2026 · 16 (28s)
DOI: 10.25258/ijddt.16.28s.23 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.05.2026. Verfasst von Madhavi Chepuri und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The drawbacks of conventional formulations and solid lipid nanoparticles (slns) were addressed by the development of nanostructured lipid carriers (nlcs), an improved lipid-based drug delivery method. Nlcs create a disordered lipid matrix by combining liquid and solid lipids, which improves long-term physical stability, decreases drug ejection throughout storage, and boosts drug loading capacity. For both hydrophilic and lipophilic medications, these systems enhance bioavailability, boost therapeutic efficacy, and offer regulated and prolonged drug release. In addition, nlcs show excellent biocompatibility, low toxicity, and adaptability for administration through oral, topical, parenteral, and ocular routes. Continued progress in formulation techniques and characterization methods has further reinforced their potential in targeted and personalized drug delivery
Zitieren
APA
Chepuri, M., & Sirikonda, S. (2026). Nanostructured Lipid Carriers: An Innovative Approach To Drug Delivery. International Journal of Drug Delivery Technology, 16(28s). https://doi.org/10.25258/ijddt.16.28s.23
Vancouver
Chepuri M, Sirikonda S. Nanostructured Lipid Carriers: An Innovative Approach To Drug Delivery. International Journal of Drug Delivery Technology. 2026;16(28s). doi:10.25258/ijddt.16.28s.23
BibTeX
@article{Chepuri2026,
author = {Chepuri, Madhavi and Sirikonda, Swapna},
title = {Nanostructured Lipid Carriers: An Innovative Approach To Drug Delivery},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {28s},
doi = {10.25258/ijddt.16.28s.23}
}
EUVIMED